Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the ISBP 2022 Conference
September 15, 2022 16:20 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science...
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advancements in Producing PHA Bioplastic in Camelina at the CROPS 2022: Improving Agriculture Through Genomics Conference
June 15, 2022 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., June 15, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that its Chief Science...
Yield10 Bioscience Announces Recent Advances in the Development of Camelina as a Production Platform for PHA Bioplastic
March 08, 2022 08:30 ET
|
Yield10 Bioscience, Inc.
-Acre-scale seed production planned in spring 2022 -First winter PHA Camelina planting expected in fall 2022 -Research program to produce PHA co-polymers is underway WOBURN, Mass., March 08, 2022...
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
January 31, 2021 19:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced the pricing of its underwritten public offering of...
Yield10 Bioscience Announces Achievement of Proof-of-Concept Milestone for Producing PHA Bioplastic in Field Grown Camelina Plants
January 19, 2021 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced successful field testing of prototype lines of the...